Review article · 2008 · Open access

Effectiveness of second generation antipsychotics: A systematic review of randomized trials

Erik Johnsen, Hugo Arild Jørgensen

BMC Psychiatry, 8(1), 31 · Published 25 April 2008 · DOI 10.1186/1471-244x-8-31

Open PDFView at the publisherCite this paper

In brief

“Effectiveness of second generation antipsychotics: A systematic review of randomized trials” is a 2008 review article by Erik Johnsen and Hugo Arild Jørgensen, published in BMC Psychiatry. OpenAlex counts 87 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at BMC Psychiatry.

Citations
87
Most cited in
2020 (4)
Field-weighted impact
1.35
References
57
Authors
2

Abstract

BACKGROUND: Systematic reviews based on efficacy trials are inconclusive about which second generation antipsychotic drug (SGA) should be preferred in normal clinical practice, and studies with longer duration and more pragmatic designs are called for. Effectiveness studies, also known as naturalistic, pragmatic, practical or real life studies, adhere to these principles as they aim to mimic daily clinical practice and have longer follow-up. OBJECTIVE: To review the head-to-head effectiveness of SGAs in the domains of global outcomes, symptoms of disease, and tolerability. METHODS: Searches were made in Embase, PubMED, and the Cochrane central register of controlled trials for effectiveness studies published from 1980 to 2008, week 1. Different combinations of the keywords antipsychotic*, neuroleptic* AND open, pragmatic, practical, naturalistic, real life, effectiveness, side effect*, unwanted effect*, tolera* AND compar* AND random* were used. RESULTS: Sixteen different reports of randomized head-to-head comparisons of SGA effectiveness were located. There were differences regarding sample sizes, inclusion criteria and follow-up periods, as well as sources of financial sponsorship. In acute-phase and first-episode patients no differences between the SGAs were disclosed regarding alleviating symptoms of disease. Olanzapine was associated with more weight gain and adverse effects on serum lipids. In the chronic phase patients olanzapine groups had longer time to discontinuation of treatment and better treatment adherence compared to other SGAs. The majority of studies found no differences between the SGAs in alleviating symptoms of psychosis in chronically ill patients. Olanzapine was associated with more metabolic adverse effects compared to the others SGAs. There were surprisingly few between-drug differences regarding side effects. First generation antipsychotics were associated with lower total mental health care costs in 2 of 3 studies on chronically ill patients, but were also associated with more extrapyramidal side effects compared to the SGAs in several studies. CONCLUSION: In chronically ill patients olanzapine may have an advantage over other SGAs regarding longer time to treatment discontinuation and better drug adherence, but the drug is also associated with more metabolic side effects. More effectiveness studies on first-episode psychosis are needed.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Johnsen, E., & Jørgensen, H. A. (2008). Effectiveness of second generation antipsychotics: A systematic review of randomized trials. BMC Psychiatry, 8(1), 31. https://doi.org/10.1186/1471-244x-8-31

MLA 9

Johnsen, Erik, and Hugo Arild Jørgensen. “Effectiveness of second generation antipsychotics: A systematic review of randomized trials.” BMC Psychiatry, vol. 8, no. 1, 2008, p. 31. https://doi.org/10.1186/1471-244x-8-31.

Chicago

Johnsen, Erik and Hugo Arild Jørgensen. 2008. “Effectiveness of second generation antipsychotics: A systematic review of randomized trials.” BMC Psychiatry 8 (1): 31. https://doi.org/10.1186/1471-244x-8-31.

Harvard

Johnsen, E. and Jørgensen, H. A. (2008) ‘Effectiveness of second generation antipsychotics: A systematic review of randomized trials’, BMC Psychiatry, 8(1), p. 31. doi:10.1186/1471-244x-8-31.

IEEE

E. Johnsen and H. A. Jørgensen, “Effectiveness of second generation antipsychotics: A systematic review of randomized trials,” BMC Psychiatry, vol. 8, no. 1, p. 31, 2008, doi: 10.1186/1471-244x-8-31.

BibTeX

@article{johnsen2008effectiveness,
  title     = {{Effectiveness of second generation antipsychotics: A systematic review of randomized trials}},
  author    = {Johnsen, Erik and Jørgensen, Hugo Arild},
  journal   = {BMC Psychiatry},
  year      = {2008},
  volume    = {8},
  number    = {1},
  pages     = {31},
  doi       = {10.1186/1471-244x-8-31},
  url       = {https://doi.org/10.1186/1471-244x-8-31}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
201833
201911
202044
202144
202244
202311
202411
202522
202611

Its field-weighted citation impact is 1.35: it has been cited 1.35 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • atypical antipsychotics
  • olanzapine
  • head-to-head comparison
  • first-episode psychosis
  • chronic psychosis
  • medication adherence
  • time to treatment discontinuation
  • metabolic side effects

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Johnsen, E., & Jørgensen, H. A. (2008). Effectiveness of second generation antipsychotics: A systematic review of randomized trials. BMC Psychiatry, 8(1), 31. https://doi.org/10.1186/1471-244x-8-31

How many times has this paper been cited?

87 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at BMC Psychiatry: sign in and open the PDF from this page.

Who wrote this paper?

Erik Johnsen, Hugo Arild Jørgensen.

What is the DOI of this paper?

10.1186/1471-244x-8-31, permanently at https://doi.org/10.1186/1471-244x-8-31. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.